| Literature DB >> 35166416 |
Haotian Xin1, Hongwei Wen2,3, Mengmeng Feng1, Yian Gao4, Chaofan Sui4, Nan Zhang4, Changhu Liang4, Lingfei Guo4.
Abstract
We aimed to investigate alterations in functional brain networks and assess the relationship between functional impairment and topological network changes in cerebral small vessel disease (CSVD) patients with and without cerebral microbleeds (CMBs). We constructed individual whole-brain, region of interest (ROI) level functional connectivity (FC) networks for 24 CSVD patients with CMBs (CSVD-c), 42 CSVD patients without CMBs (CSVD-n), and 36 healthy controls (HCs). Then, we used graph theory analysis to investigate the global and nodal topological disruptions between groups and relate network topological alterations to clinical parameters. We found that both the CSVD and control groups showed efficient small-world organization in FC networks. However, compared to CSVD-n patients and controls, CSVD-c patients exhibited a significantly decreased clustering coefficient, global efficiency, and local efficiency and an increased shortest path length, indicating a disrupted balance between local specialization and global integration in FC networks. Although both the CSVD and control groups showed highly similar hub distributions, the CSVD-c group exhibited significantly altered nodal betweenness centrality (BC), mainly distributed in the default mode network (DMN), attention, and visual functional areas. There were almost no global or regional alterations between CSVD-n patients and controls. Furthermore, the altered nodal BC of the right anterior/posterior cingulate gyrus and left cuneus were significantly correlated with cognitive parameters in CSVD patients. These results suggest that CSVD patients with and without CMBs had segregated disruptions in the topological organization of the intrinsic functional brain network. This study advances our current understanding of the pathophysiological mechanisms underlying CSVD.Entities:
Keywords: cerebral microbleeds; cerebral small vessel disease; functional connectivity; graph theory; topological organization
Mesh:
Year: 2022 PMID: 35166416 PMCID: PMC9057099 DOI: 10.1002/hbm.25808
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.399
The 90 cortical and subcortical regions of interest defined in our study
| Regions | Abbr. | Regions | Abbr. |
|---|---|---|---|
| Precentral gyrus | PreCG | Lingual gyrus | LING |
| Superior frontal gyrus, dorsolateral | SFGdor | Superior occipital gyrus | SOG |
| Superior frontal gyrus, orbital part | ORBsup | Middle occipital gyrus | MOG |
| Middle frontal gyrus | MFG | Inferior occipital gyrus | IOG |
| Middle frontal gyrus orbital part | ORBmid | Fusiform gyrus | FFG |
| Inferior frontal gyrus, opercular part | IFGoperc | Postcentral gyrus | PoCG |
| Inferior frontal gyrus, triangular part | IFGtriang | Superior parietal gyrus | SPG |
| Inferior frontal gyrus, orbital part | ORBinf | Inferior parietal, but supramarginal and angular gyri | IPL |
| Rolandic operculum | ROL | Supramarginal gyrus | SMG |
| Supplementary motor area | SMA | Angular gyrus | ANG |
| Olfactory cortex | OLF | Precuneus | PCUN |
| Superior frontal gyrus, medial | SFGmed | Paracentral lobule | PCL |
| Superior frontal gyrus, medial orbital | ORBsupmed | Caudate nucleus | CAU |
| Gyrus rectus | REC | Lenticular nucleus, putamen | PUT |
| Insula | INS | Lenticular nucleus, pallidum | PAL |
| Anterior cingulate and paracingulate gyri | ACG | Thalamus | THA |
| Median cingulate and paracingulate gyri | DCG | Heschl gyrus | HES |
| Posterior cingulate gyrus | PCG | Superior temporal gyrus | STG |
| Hippocampus | HIP | Temporal pole: superior temporal gyrus | TPOsup |
| Parahippocampal gyrus | PHG | Middle temporal gyrus | MTG |
| Amygdala | AMYG | Temporal pole: middle temporal gyrus | TPOmid |
| Calcarine fissure and surrounding cortex | CAL | Inferior temporal gyrus | ITG |
| Cuneus | CUN |
Global and local topological properties used in the study
| Global network properties | |
|---|---|
| Global efficiency, |
|
| Local efficiency, |
|
| Shortest path length, |
|
| Clustering coefficient, |
|
| Normalized |
|
| Normalized |
|
| Small‐worldness, σ |
|
Demographic and clinical characteristics of CSVD patients and controls
| Characteristics | CSVD‐c | CSVD‐n | Controls |
|
| ||
|---|---|---|---|---|---|---|---|
| G1 versus G3 | G1 versus G2 | G2 versus G3 | |||||
| Gender | 14M/10F | 20M/22F | 17M/19F | 0.646χ2 | ‐ | ‐ | ‐ |
| Age (years) | 67.54 ± 6.00 | 66.33 ± 5.25 | 64.14 ± 8.57 | 0.140 | ‐ | ‐ | ‐ |
| Education (years) | 11.33 ± 2.87 | 11.43 ± 2.41 | 12.72 ± 3.44 | 0.093 | ‐ | ‐ | ‐ |
| BMI | 26.26 ± 3.37 | 24.68 ± 3.26 | 25.42 ± 2.85 | 0.147 | ‐ | ‐ | ‐ |
| Smoking, | 7 (29) | 8 (19) | 10 (28) | ‐ | ‐ | ‐ | ‐ |
| Hypertension, | 22 (92) | 36 (86) | 12 (33) | <0.001χ2 | ‐ | ‐ | ‐ |
| Diabetes, | 9 (38) | 8 (19) | 4 (11) | 0.044χ2 | ‐ | ‐ | ‐ |
| Hyperlipidemia, | 15 (63) | 13 (31) | 5 (14) | <0.001χ2 | ‐ | ‐ | ‐ |
| MoCA | 25.52 ± 2.82 | 27.55 ± 0.89 | 28.66 ± 0.87 |
|
|
|
|
| AVLT | 54.48 ± 16.91 | 64.93 ± 9.55 | 68.14 ± 8.47 |
|
|
| N.S. |
| SDMT | 23.26 ± 10.94 | 30.22 ± 9.05 | 39.63 ± 14.32 |
|
|
|
|
| SCWT | 187.13 ± 71.17 | 145.90 ± 27.55 | 134.83 ± 38.12 |
|
|
| N.S. |
| TMT‐A + B | 346.17 ± 175.25 | 259.78 ± 76.34 | 213.26 ± 101.20 |
|
|
| N.S. |
| FD_Jenkinson | 0.13 ± 0.07 | 0.13 ± 0.08 | 0.11 ± 0.44 | 0.339 | ‐ | ‐ | ‐ |
| WMHs | 1.96 ± 0.91 | 1.57 ± 0.70 | ‐ | 0.057 b | ‐ | ‐ | ‐ |
| Lacunes | 0.88 ± 0.99 | 0.05 ± 0.22 | ‐ | <0.001 | ‐ | ‐ | ‐ |
Abbreviations: AVLT, sum of Rey Auditory Verbal Learning Test (N1‐7); BMI, body mass index; CSVD, cerebral small vessel disease; CSVD‐c, CSVD with CMBs; CSVD‐n, CSVD without CMBs; FD_Jenkinson, frame‐wise displacement (Jenkinson et al., 2002); G1, CSVD‐c group; G2, CSVD‐n group; G3, control group; MoCA, Montreal Cognitive Assessment; N.S., not significant; SCWT, sum of Stroop Color‐Word Test (stroop1‐3); SDMT, Symbol Digit Modalities Test; TMT, the Trail‐Making Test; TMT A + B, sum of TMT‐A and TMT‐B; χ2, chi‐square test; WMHs, white matter hyperintensities.
ANOVA test.
Wilcoxon test.
FIGURE 1Differences in global topological properties of functional networks among the three groups. Data points marked with a star indicate significant (p < 0.05, ANOVA with LSD post hoc test) intergroup differences in the global network metric under a corresponding sparsity threshold
Group comparisons of AUC values of global network properties
| Group |
|
|
|
|
| γ |
|
|---|---|---|---|---|---|---|---|
| CSVD‐c | 0.348 ± 0.035 | 0.453 ± 0.061 | 2.947 ± 0.240 | 0.352 ± 0.056 | 1.589 ± 0.216 | 1.128 ± 0.025 | 1.389 ± 0.179 |
| CSVD‐n | 0.371 ± 0.042 | 0.490 ± 0.069 | 2.790 ± 0.275 | 0.396 ± 0.071 | 1.609 ± 0.230 | 1.132 ± 0.034 | 1.401 ± 0.198 |
| HC | 0.379 ± 0.042 | 0.501 ± 0.070 | 2.722 ± 0.254 | 0.404 ± 0.071 | 1.621 ± 0.209 | 1.125 ± 0.027 | 1.418 ± 0.150 |
|
|
|
|
|
| 0.849 | 0.539 | 0.823 |
|
|
|
|
|
| ‐ | ‐ | ‐ |
|
| 0.404 | 0.468 | 0.260 | 0.580 | ‐ | ‐ | ‐ |
|
|
|
|
|
|
|
|
|
Abbreviations: ANOVA, analysis of variance; AUC, area under the curve; CSVD, cerebral small vessel disease; HC, healthy controls.
p < 0.05 (ANOVA, LSD post‐hoc test).
Hub regions of functional networks in both CSVD and control groups
| CSVD‐c | CSVD‐n | HC | |||
|---|---|---|---|---|---|
| Regions |
| Regions |
| Regions |
|
| SMA.R | 74.78 ± 61.24 | SMA.R | 59.04 ± 40.90 | SMA.R | 62.64 ± 70.21 |
| DCG.R | 64.96 ± 51.08 | DCG.R | 65.90 ± 47.95 | DCG.R | 72.70 ± 62.56 |
| MOG.L | 72.75 ± 80.34 | MOG.L | 83.60 ± 66.89 | MOG.L | 81.34 ± 65.13 |
| STG.R | 68.21 ± 56.49 | STG.R | 72.43 ± 54.56 | STG.R | 81.02 ± 60.96 |
| TPOsup.L | 62.80 ± 59.51 | TPOsup.L | 67.20 ± 50.79 | TPOsup.L | 82.77 ± 77.46 |
| TPOsup.R | 67.93 ± 63.83 | TPOsup.R | 62.12 ± 45.47 | TPOsup.R | 81.50 ± 57.73 |
| MTG.L | 100.11 ± 82.55 | MTG.L | 91.42 ± 68.35 | MTG.L | 93.85 ± 74.93 |
| MTG.R | 71.56 ± 47.22 | MTG.R | 65.77 ± 50.39 | MTG.R | 66.54 ± 69.76 |
| ITG.L | 76.59 ± 59.14 | ITG.L | 64.36 ± 57.06 | ITG.L | 66.48 ± 52.90 |
| ITG.R | 83.29 ± 65.71 | ITG.R | 90.26 ± 72.43 | ITG.R | 115.86 ± 89.99 |
| FFG.L | 74.15 ± 70.93 |
| 58.47 ± 39.18 |
| 64.01 ± 57.42 |
| FFG.R | 57.33 ± 62.16 |
| 59.08 ± 59.67 |
| 70.68 ± 55.31 |
| MFG.L | 64.54 ± 40.49 |
| 71.61 ± 55.36 | ||
Abbreviations: B nodal represents the AUC value (mean ± SD) of nodal betweenness centrality across thresholds; CSVD, cerebral small vessel disease; HC, healthy control.
FIGURE 2Hub region distributions of the functional networks for both groups. The hub nodes are shown with different node sizes, indicating their nodal betweenness centrality values. The brain graphs were visualized by using BrainNet Viewer software (http://www.nitrc.org/projects/bnv/). For the abbreviations of the nodes, see Table 1
Brain regions showing significantly altered nodal betweenness centrality among three groups for functional networks
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
| Module | Region | CSVD‐c | CSVD‐n | Control | G1 versus G3 | G1 versus G2 | G2 versus G3 | |
| DMN | ORBsup.R | 23.56 ± 19.79 | 39.22 ± 33.64 | 53.85 ± 47.50 |
|
| N.S. | N.S. |
| Attention | MFG.L | 64.54 ± 41.36 | 43.73 ± 38.93 | 39.28 ± 32.28 |
|
|
| N.S. |
| Attention | IFGoperc.L | 19.09 ± 14.80 | 38.75 ± 40.98 | 25.34 ± 27.77 |
| N.S. |
| N.S. |
| Sensory/motor | INS.L | 39.08 ± 34.88 | 44.55 ± 46.92 | 25.21 ± 28.69 |
| N.S. | N.S. |
|
| DMN | ACG.R | 41.71 ± 48.32 | 27.47 ± 30.29 | 22.46 ± 27.54 |
|
| N.S. | N.S. |
| DMN | PCG.R | 15.10 ± 18.90 | 21.45 ± 21.29 | 29.82 ± 35.26 |
|
| N.S. | N.S. |
| Subcortical | HIP.L | 37.79 ± 30.32 | 16.59 ± 25.85 | 27.86 ± 42.68 |
| N.S. |
| N.S. |
| Vision | CUN.L | 40.15 ± 34.63 | 29.01 ± 42.20 | 18.03 ± 20.94 |
|
| N.S. | N.S. |
| Attention | ANG.L | 41.10 ± 42.78 | 26.39 ± 21.35 | 22.17 ± 20.54 |
|
|
| N.S. |
Note: The modular division of brain regions is based on previous study (Yong et al., 2009).
Abbreviations: ANOVA, analysis of variance; B nodal represents the AUC values (mean ± SD) of the nodal betweenness centrality of each group; CSVD, cerebral small vessel disease; DMN, default mode network; G1, CSVD with CMBs (CSVD‐c) group; G2, CSVD without CMBs (CSVD‐n) group; G3, control group, N.S., not significant.
FIGURE 3The differences in nodal betweenness centrality of the functional networks across the CSVD‐c, CSVD‐n, and HC groups. The disrupted nodes with significantly decreased or increased nodal betweenness centrality are shown in blue or red, and the scaled node sizes indicate the F values of ANOVA. For the abbreviations of the nodes, see Table 1
FIGURE 4Correlations between nodal topological properties and clinical parameters. Of note, the coordinate values of both the X axis (clinical parameter) and Y axis (nodal BC) do not reflect the initial values of these variables when considering age, sex and mean FD as covariates. For the abbreviations of the nodes, see Tables 1 and 3